Finance · the U.S. · October 13, 2026
From MarketWatch
The Federal Trade Commission and seven states say Shkreli should be held in contempt
Reported by MarketWatch, October 13, 2026. Read the full story at MarketWatch →
‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks
A finance story from the U.S., reported by MarketWatch.
More finance from the U.S.
- Kimberly Guilfoyle resigns as ambassador to Greece at White House's request · CNBC Top News
- Paul Tudor Jones is bullish on oil, says it could rally another $20-$25 because of Iran conflict · CNBC Top News
- Trump's diesel deal with Russia equals less than two weeks of U.S. demand · CNBC Top News
- We're adding to a consumer staples stock in advance of a big catalyst · CNBC Top News
- President Donald Trump Asks Kimberly Guilfoyle To Resign as Greece Ambassador—Threatening Her Glamorous New Life Abroad · Realtor.com News
- ‘A very tough market out there’: U.S. home sales fell 2.2% from last year as mortgage rates and prices rise · Fortune
- JPMorgan, Goldman Sachs, Citigroup and Wells Fargo post strong profits, but warn rising interest rates and ‘sticky inflation’ will bite · Fortune
- Supreme Court will hear the Trump administration’s argument that DOGE is exempt from the public-records law · Fortune